跳至主要内容
临床试验/KCT0007902
KCT0007902尚未招募未知

Adequate infusion rate of remimazolam for induction of general anesthesia in elderly patients aged 65 or older

Samsung Medical Center0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
65(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Americal Society of Anesthesiologists physical status I - III
  • 2) Aged 65 years and more
  • 3) Elective surgery under general anesthesia

排除标准

  • 1) patients who are contraindicated in benzodiazepine (e,g., allergy to drug or have a history of hypersensitivity reactions)
  • 2) drug or alcohol addiction
  • 3) neuromuscular disease or mental illness
  • 4) metabolic disease
  • 5) emergency surgery
  • 6) body mass index >30kg/m2 or <18.5kg/m2
  • 7) patient's refusal
  • 8) patients in shock or coma
  • 9) patients who are contraindicated to remiamazolam such as acute narrow-angle glaucoma, sleep apnea, severe or acute respiratory failure, galactose intolerance, lactase deficiency, glucose-galactose malabsorption, severe hypersensitivity to dextran 40.

研究者

相似试验